Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis
X He, J Ji, C Liu, Z Luo, J Tang, H Yan, L Guo - Annals of Medicine, 2024 - Taylor & Francis
Objective The association between nutritional status and prognosis of idiopathic pulmonary
fibrosis (IPF) remains unclear. This systematic review and meta-analysis aimed to explore …
fibrosis (IPF) remains unclear. This systematic review and meta-analysis aimed to explore …
Colchicine is a weapon for managing the heart disease among interstitial lung disease with viral infection: have we found the holy grail?
Background This study investigated the effect of colchicine use on the risks of heart disease
(HD), pericarditis, endocarditis, myocarditis, cardiomyopathy, cardiac arrhythmia, and …
(HD), pericarditis, endocarditis, myocarditis, cardiomyopathy, cardiac arrhythmia, and …
Enhancing Outcomes in Chronic Fibrotic Interstitial Lung Disease Through Aggressive Management of Nintedanib-Induced Adverse Drug Reactions: A Retrospective …
YW Chang, MY Tsai, YP Chang, CC Liao… - Drugs-Real World …, 2024 - Springer
Abstract Background and Objectives Nintedanib, a tyrosine kinase inhibitor, is integral in
slowing pulmonary fibrosis progression in chronic fibrotic interstitial lung disease (ILD) …
slowing pulmonary fibrosis progression in chronic fibrotic interstitial lung disease (ILD) …